Review of Post-Marketing Safety Data on Tapentadol, a Centrally Acting Analgesic

INTRODUCTION: Tapentadol is a centrally acting analgesic that has been available for the management of acute and chronic pain in routine clinical practice since 2009. METHODS: This is the first integrated descriptive analysis of post-marketing safety data following the use of tapentadol in a broad r...

Descripción completa

Detalles Bibliográficos
Autores principales: Stollenwerk, Ariane, Sohns, Melanie, Heisig, Fabian, Elling, Christian, von Zabern, Detlef
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5778188/
https://www.ncbi.nlm.nih.gov/pubmed/29270779
http://dx.doi.org/10.1007/s12325-017-0654-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5778188/
https://www.ncbi.nlm.nih.gov/pubmed/29270779
http://dx.doi.org/10.1007/s12325-017-0654-0

Ejemplares similares